ORCL gained 6% on Tuesday to close at $126.19, a partial recovery from Monday's sharp fall after the company announced a $20 billion capital raise. The stock is still down 3.3% on the week, 11% over the past month, and roughly 46% below the analyst consensus target of $235.46. Options positioning captures the tension well. The put/call ratio pulled back slightly to 0.97 from…
ORCL cost to borrow doubles to 0.35%, up 112% in one week.
Key data as of 8 Nov 2026
ORCL cost to borrow doubles to 0.35%, up 112% in one week.
ORCL Stephens upgrades to Overweight, raises price target to $213 from $185, implying 63% upside from $130.67 close.
A new long-form analysis for ORCL this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumORCL enters its October 28 earnings report having shed 15% over the past month, closing at $126.16, yet short sellers have barely moved. Short interest has edged up just 0.8% on the week to 48.1 million shares, equal…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ORCL — free to start on ORTEX.
Sign up for free →Open ORCL on ORTEX